FrancophonIA/ELRC3.0 huggingface dataset:
English: How does Ibandronic Acid Sandoz work?
Croatian: Kako djeluje Ibandronatna kiselina Sandoz?
English: How has Ibandronic Acid Sandoz been studied?
Croatian: Kako je lijek Ibandronatna kiselina Sandoz ispitivan?
English: Your doctor will tell you exactly how many tablets of Xiliarx to take.
Croatian: Liječnik će Vam reći točno koliko tableta Xiliarxa trebate uzimati.
English: Tell your doctor or pharmacist if you are taking, have recently taken or might take any other medicines.
Croatian: Obavijestite svog liječnika ili ljekarnika ako uzimate , nedavno ste uzeli ili biste mogli uzeti bilo koje druge lijekove.
English: Talk to your doctor, pharmacist or nurse before taking Xiliarx
Croatian: Obratite se svom liječniku, ljekarniku ili medicinskoj sestri prije nego uzmete Xiliarx
English: • Take Xiliarx every day for as long as your doctor tells you.
Croatian: • Xiliarx uzimajte svaki dan onoliko dugo koliko Vam liječnik kaže.
English: Do not stop taking Xiliarx unless your doctor tells you to.
Croatian: Nemojte prestati uzimati Xiliarx osim ako Vam to ne kaže liječnik.
English: However, the magnitude of change is not clinically significant, so that Xiliarx can be given with or without food.
Croatian: Međutim, stupanj promjene nije klinički značajan pa se Xiliarx može primjenjivati s hranom ili bez nje.
English: If you take too many Xiliarx tablets, or if someone else has taken your medicine, talk to your doctor straight away.
Croatian: Ako uzmete previše tableta Xiliarxa, ili ako je netko drugi uzeo Vaš lijek, odmah se javite svom liječniku.
English: EU/1/08/486/011 336 tablets (3 packs of 112)
Croatian: EU/1/08/486/011 336 tableta (3 pakiranja od 112)
English: The amount of Xiliarx people have to take varies depending on their condition.
Croatian: Količina Xiliarxa koju ljudi moraju uzimati ovisi o njihovu stanju.
English: You are also advised to pay particular attention to new onset of blisters or ulcers while taking Xiliarx.
Croatian: Također Vam se savjetuje da posvetite posebnu pozornost novoj pojavi mjehurića ili čireva dok uzimate Xiliarx.
English: EU/1/08/486/001 7 tablets EU/1/08/486/002 14 tablets EU/1/08/486/003 28 tablets EU/1/08/486/004 30 tablets EU/1/08/486/005 56 tablets EU/1/08/486/006 60 tablets EU/1/08/486/007 90 tablets EU/1/08/486/008 112 tablets EU/1/08/486/009 180 tablets EU/1/08/486/010 336 tablets
Croatian: EU/1/08/486/001 7 tableta EU/1/08/486/002 14 tableta EU/1/08/486/003 28 tableta EU/1/08/486/004 30 tableta EU/1/08/486/005 56 tableta EU/1/08/486/006 60 tableta EU/1/08/486/007 90 tableta EU/1/08/486/008 112 tableta EU/1/08/486/009 180 tableta EU/1/08/486/010 336 tableta
English: • if you have type 1 diabetes (i.e. your body does not produce insulin) or if you have a condition called diabetic ketoacidosis.
Croatian: • ako imate šećernu bolest tipa 1 (odnosno Vaše tijelo ne stvara inzulin) ili ako imate stanje koje se zove dijabetička ketoacidoza.
English: If you take more Xiliarx than you should
Croatian: Ako uzmete više Xiliarxa nego što ste trebali
English: If you think you may be allergic to vildagliptin or any of the other ingredients of Xiliarx, do not take this medicine and talk to your doctor.
Croatian: Ako mislite da biste mogli biti alergični na vildagliptin ili bilo koji od ostalih sastojaka Xiliarxa, nemojte uzeti ovaj lijek i porazgovarajte sa svojim liječnikom.
English: Some symptoms need immediate medical attention: You should stop taking Xiliarx and see your doctor immediately if you experience the following side effects:
Croatian: Neki simptomi zahtijevaju hitnu medicinsku pomoć: Prestanite uzimati Xiliarx i odmah otiđite svom liječniku ako osjetite sljedeće nuspojave:
English: Your doctor may wish to alter your dose of Xiliarx if you are taking other medicines such as: - thiazides or other diuretics (also called water tablets) - corticosteroids(generally used to treat inflammation) - thyroid medicines - certain medicines affecting the nervous system.
Croatian: Liječnik će Vam možda željeti promijeniti dozu Xiliarxa ako uzimate druge lijekove kao što su: - tijazidi ili drugi diuretici (također se zovu tablete za vodu) - kortikosteroidi (općenito se koristeza liječenje upale) - lijekovi za liječenje štitnjače - određeni lijekovi koji utječu na živčani sustav.
English: Xiliarx is not a substitute for insulin in insulin-requiring patients.
Croatian: Xiliarx nije zamjena za inzulin u bolesnika koji trebaju inzulin.
English: The active substance of Xiliarx, vildagliptin, belongs to a group of medicines called “oral antidiabetics”.
Croatian: Djelatna tvar Xiliarxa, vildagliptin, pripada skupini lijekova koji se nazivaju „oralni antidijabetici“.
English: What Xiliarx is and what it is used for
Croatian: Što je Xiliarx i za što se koristi
English: Do not take Xiliarx:
Croatian: Nemojte uzimati Xiliarx:
English: Other medicines and Xiliarx
Croatian: Drugi lijekovi i Xiliarx
English: What Xiliarx is and what it is used for What you need to know before you take Xiliarx How to take Xiliarx
Croatian: Što je Xiliarx i za što se koristi Što morate znati prije nego počnete uzimati Xiliarx Kako uzimati Xiliarx
English: Xiliarx contains lactose (milk sugar).
Croatian: Xiliarx sadrži laktozu (mliječni šećer).
English: Information on the likely symptoms of overdose was taken from a rising dose tolerability study in healthy subjects given Xiliarx for 10 days.
Croatian: Informacije o mogućim simptomima predoziranja uzete su iz ispitivanja podnošljivosti povećanja doze u zdravih ispitanika koji su primali Xiliarx tijekom 10 dana.
English: No studies on the effect on human fertility have been conducted for Xiliarx (see section 5.3).
Croatian: Nisu provedena nikakva ispitivanja o učinku Xiliarxa na plodnost u ljudi (vidjeti dio 5.3).
English: No data are available (see also section 5.1).
Croatian: Nemadostupnih podataka (vidjeti također dio 5.1).
English: • if you have moderate or severe kidney disease (you will need to take a lower dose of Xiliarx).
Croatian: • ako imate umjerenu do tešku bolest bubrega (trebat ćete uzeti nižu dozu Xiliarxa).
English: You should not use Xiliarx during pregnancy.
Croatian: Ne smijete uzimati Xiliarx tijekom trudnoće.
English: Due to lack of human data, Xiliarx should not be used during pregnancy.
Croatian: Zbog nedovoljno podataka u ljudi, Xiliarx se ne smije primjenjivati tijekom trudnoće.
English: The usual dose of Xiliarx is either:
Croatian: Uobičajena doza Xiliarxa iznosi ili:
English: The safety and efficacy of Xiliarx in children and adolescents (< 18 years) have not been established.
Croatian: Sigurnost i djelotvornost Xiliarxa u djece i adolescenata (<18 godina) nisu još ustanovljene.
English: Oral use Xiliarx can be administered with or without a meal (see also section 5.2).
Croatian: Xiliarx se može uzimati uz obrok ili bez obroka (vidjeti također dio 5.2).
English: Xiliarx should not be used in patients with type 1 diabetes or for the treatment of diabetic ketoacidosis.
Croatian: Xiliarx se ne smije primjenjivati u bolesnika sa šećernom bolešću tipa 1 ili za liječenje dijabetičke ketoacidoze.
English: Therefore Xiliarx should be used with caution in these patients (see also sections 4.2, 5.1 and 5.2).
Croatian: Zbog toga se u tih bolesnika Xiliarx treba primjenjivati s oprezom (vidjeti također dijelove 4.2, 5.1 i 5.2).
English: What you need to know before you take Xiliarx
Croatian: Što morate znati prije nego počnete uzimati Xiliarx
English: Your doctor will prescribe Xiliarx either alone or together with certain other antidiabetic medicines which you will already be taking, if these have not proved sufficiently effective to control diabetes.
Croatian: Liječnik će Vam propisati Xiliarx bilo kao monoterapiju ili u kombinaciji s nekim drugim lijekovima za liječenje šećerne bolesti koje već uzimate ako se ti drugi lijekovi nisu pokazali dostatno djelotvornima u kontroli šećerne bolesti.
English: It is not known if Xiliarx passes into breast milk.
Croatian: Nije poznato prelazi li Xiliarx u majčino mlijeko.
English: Xiliarx works by making the pancreas produce more insulin and less glucagon.
Croatian: Xiliarx djeluje tako da gušterača stvara više inzulina, a manje glukagona.
English: Vildagliptin, a member of the islet enhancer class, is a potent and selective DPP-4 inhibitor.
Croatian: Vildagliptin, pripadnik skupine stimulatora Langerhansovih otočića gušterače, jaki je i selektivni DPP4 inhibitor.
English: Xiliarx is not recommended for use in children and adolescents under (< 18 years).
Croatian: Xiliarx se ne preporučuje za primjenu u djece i adolescenata (<18 godina).
English: • 50 mg daily taken as one dose in the morning if you are taking Xiliarx with another medicine called a sulphonylurea.
Croatian: • 50 mg na dan, što se uzima kao jedna doza ujutro ako uzimate Xiliarx s drugim lijekom koji se zove sulfonilureja.
English: Patients who develop jaundice or other signs suggestive of liver dysfunction should discontinue Xiliarx.
Croatian: U bolesnika koji razviju žuticu ili druge znakove koji upućuju na poremećaj jetrene funkcije treba prekinuti liječenje Xiliarxom.
English: • Do not use any Xiliarx pack that is damaged or shows signs of tampering.
Croatian: • Xiliarx se ne smije upotrijebiti ako je kutija oštećena ili postoje vidljivi znakovi otvaranja.
English: The elimination halflife after oral administration is approximately 3 hours.
Croatian: Poluvrijeme eliminacije nakon peroralne primjene iznosi oko 3 sata.
English: A clinical trial of vildagliptin in patients with New York Heart Association (NYHA) functional class I-III showed that treatment with vildagliptin was not associated with a change in left-ventricular function or worsening of pre-existing congestive heart failure (CHF) versus placebo.
Croatian: Kliničko ispitivanje vildagliptina u bolesnika s NYHA funkcionalnom klasom I-III pokazalo je da liječenje vildagliptinom nije povezano s promjenom u funkciji lijeve klijetke ili pogoršanjem već postojećeg kongestivnog zatajenja srca (KZS) u usporedbi s placebom.
English: Adverse reactions reported in patients who received Xiliarx in double-blind studies as monotherapy and add-on therapies are listed below for each indication by system organ class and absolute frequency.
Croatian: Nuspojave zabilježene u bolesnika koji su primali Xiliarx u dvostruko slijepim ispitivanjima kao monoterapiju i kao dodatnu terapiju navedene su niže za svaku indikaciju prema klasifikaciji organskih sustava i apsolutnoj učestalosti.
English: What Xiliarx looks like and contents of the pack Xiliarx 50 mg tablets are round, white to light yellowish and flat, with “NVR” on one side and “FB” on the other.
Croatian: Xiliarx 50 mg tablete su okrugle, bijele do svijetložućkaste i ravne, s oznakom „NVR“ na jednoj strani i „FB“ na drugoj strani.
English: In patients with moderate or severe renal impairment or with end-stage renal disease (ESRD), the recommended dose of Xiliarx is 50 mg once daily (see also sections 4.4, 5.1 and 5.2).
Croatian: U bolesnika s umjerenim ili teškim oštećenjem bubrega ili u bolesnika u završnoj fazi bubrežne bolesti preporučena doza Xiliarxa je 50 mg jedanput na dan (vidjeti također dijelove 4.4, 5.1 i 5.2).
English: Xiliarx 50 mg tablets are available in packs containing 7, 14, 28, 30, 56, 60, 90, 112, 180 or 336 tablets and in multipacks comprising 3 cartons, each containing 112 tablets.
Croatian: Xiliarx 50 mg tablete su dostupne u pakiranjima koja sadrže 7, 14, 28, 30, 56, 60, 90, 112, 180 ili 336 tableta i u višestrukim pakiranjima koja sadrže 3 kutije, a svaka sadrži 112 tableta.
English: Liver function should be monitored during treatment with Xiliarx at three-month intervals during the first year and periodically thereafter.
Croatian: Jetrenu funkciju treba pratiti tijekom liječenja Xiliarxom u razmacima od tri mjeseca tijekom prve godine liječenja te povremeno nakon toga.
English: If a dose of Xiliarx is missed, it should be taken as soon as the patient remembers.
Croatian: Ako je bolesnik zaboravio uzeti dozu Xiliarxa, treba je uzeti čim se sjeti.
English: Following withdrawal of treatment with Xiliarx and LFT normalisation, treatment with Xiliarx should not be reinitiated.
Croatian: Nakon prekida liječenja Xiliarxom i normalizacije testova jetrene funkcije ne smije se ponovno započeti primjena Xiliarxa.
English: - If you have any further questions, ask your doctor, pharmacist or nurse.
Croatian: - Ako imate dodatnih pitanja, obratite se liječniku, ljekarniku ili medicinskoj.
English: Xiliarx should not be used in patients with hepatic impairment, including patients with pre-treatment alanine aminotransferase (ALT) or aspartate aminotransferase (AST) > 3x the upper limit of normal (ULN) (see also sections 4.4 and 5.2).
Croatian: Xiliarx se ne smije primjenjivati u bolesnika s oštećenjem jetre, uključujući bolesnike u kojih su vrijednosti alanin aminotransferaze (ALT) ili aspartat aminotransferaze (AST) prije početka liječenja bile >3x vrijednosti gornje granice normale (GGN) (vidjeti također dijelove 4.4 i 5.2).
English: Liver function tests should be performed prior to the initiation of treatment with Xiliarx in order to know the patient's baseline value.
Croatian: Testove jetrene funkcije treba napraviti prije početka liječenja Xiliarxom kako bi se utvrdile početne vrijednosti.
English: If you stop taking Xiliarx
Croatian: Ako prestanete uzimati Xiliarx
English: • if you are taking an anti-diabetic medicine known as a sulphonylurea (your doctor may want to reduce your dose of the sulphonylurea when you take it together with Xiliarx in order to avoid low blood glucose [hypoglycaemia]).
Croatian: • ako uzimate lijek protiv šećerne bolesti iz skupine sulfonilureja (kako bi se izbjegle niske vrijednosti glukoze u krvi [hipoglikemija], Vaš će Vam liječnik možda smanjiti dozu sulfonilureje kad je uzimate zajedno s Xiliarxom).
English: • 100 mg daily taken as 50 mg in the morning and 50 mg in the evening if you are taking Xiliarx alone, with another medicine called metformin or a glitazone, with a combination of metformin and a sulphonylurea, or with insulin.
Croatian: • 100 na dan, što se uzima kao doza od 50 mg ujutro i 50 mg navečer ako uzimate Xiliarx sam ili s drugim lijekom koji se zove metformin ili glitazon, u kombinaciji s metforminom i sulfonilurejom ili inzulinom.
English: Should an increase in AST or ALT of 3x ULN or greater persist, withdrawal of Xiliarx therapy is recommended.
Croatian: Potraju li povišene vrijednosti AST-a ili ALT-a na razini 3x vrijednosti GGN-e ili većoj, preporučuje se prekinuti terapiju Xiliarxom.
English: What Xiliarx contains
Croatian: Što Xiliarx sadrži
English: Some patients have had the following side effects while taking Xiliarx and insulin (with or without metformin):
Croatian: Neki su bolesnici imali sljedeće nuspojave kada su uzimali Xiliarx i inzulin (sa ili bez metformina):
English: Driving and using machines If you feel dizzy while taking Xiliarx, do not drive or use machines.
Croatian: Ako osjećate omaglicu dok uzimate Xiliarx, nemojte upravljati vozilima niti raditi sa strojevima.
English: If you forget to take Xiliarx
Croatian: Ako ste zaboravili uzeti Xiliarx
English: Xiliarx 50 mg tablets
Croatian: Xiliarx 50 mg tablete
English: How to take Xiliarx • Swallow the tablets whole with some water.
Croatian: • Tablete progutajte cijele s malo vode.
English: Xiliarx 50 mg tablets vildagliptin
Croatian: Xiliarx 50 mg tablete vildagliptin
English: How long to take Xiliarx
Croatian: Koliko dugo uzimati Xiliarx
English: Children and adolescents The use of Xiliarx in children and adolescents up to 18 years of age is not recommended.
Croatian: Djeca i adolescenti Xiliarx se ne preporučuje za primjenu u djece i adolescenata ispod 18 godina.
English: A test to determine your liver function will be performed before the start of Xiliarx treatment, at threemonth intervals for the first year and periodically thereafter.
Croatian: Testovi jetrene funkcije će se napraviti prije početka liječenja Xiliarxom, potom tijekom prve godine u razmacima od tri mjeseca te poslije toga periodički.
English: Xiliarx contains lactose
Croatian: Xiliarx sadrži laktozu
English: Xiliarx is used to treat adult patients with type 2 diabetes.
Croatian: Xiliarx se primjenjuje za liječenje bolesnika sa šećernom bolešću tipa
English: How Xiliarx works
Croatian: Kako Xiliarx djeluje
English: Xiliarx should not be used during breast-feeding.
Croatian: Xiliarx se ne smije primjenjivati tijekom dojenja.
English: Xiliarx should not be used in patients with hepatic impairment, including patients with pre-treatment ALT or AST > 3x ULN (see also sections 4.2 and 5.2).
Croatian: Xiliarx se ne smije primjenjivati u bolesnika s oštećenjem funkcije jetre, uključujući bolesnike u kojih su ALT ili AST prije početka liječenja bili >3x vrijednosti GGN (vidjeti također dijelove 4.2 i 5.2).
English: Table 5 Adverse reactions reported in patients who received Xiliarx 50 mg twice daily in combination with metformin and a sulphonylurea (N=157)
Croatian: Tablica 5 Nuspojave zabilježene u bolesnika koji su primali Xiliarx 50 mg dva puta na dan u kombinaciji s metforminom i sulfonilurejom (N=157)
English: Table 6 Adverse reactions reported in patients who received Xiliarx 100 mg daily in combination with insulin (with or without metformin) in double-blind studies (N=371)
Croatian: Tablica 6 Nuspojave zabilježene u bolesnika koji su primali Xiliarx 100 mg na dan u kombinaciji s inzulinom (s ili bez metformina) u dvostruko slijepim ispitivanjima (N=371)
English: How to take Xiliarx
Croatian: Kako uzimati Xiliarx
English: • Uncommon: Constipation
Croatian: • Često: omaglica
English: In the pioglitazone add-on study, the absolute weight increases with placebo, Xiliarx 100 mg daily were 1.4 and 2.7 kg, respectively.
Croatian: U kliničkom ispitivanju kao dodatne terapije uz pioglitazon, apsolutno povećanje tjelesne težine s placebom bilo je 1,4 kg, odnosno 2,7 kg sa 100 mg Xiliarxa na dan.
English: • The other ingredients are lactose anhydrous, microcrystalline cellulose, sodium starch glycolate
Croatian: • Drugi sastojci su bezvodna laktoza, mikrokristalična celuloza, natrijev škroboglikolat (vrste A) i magnezijev stearat.
English: Table 1 Adverse reactions reported in patients who received Xiliarx 100 mg daily in combination with metformin in double-blind studies (N=208)
Croatian: Tablica 1 Nuspojave zabilježene u bolesnika koji su primali 100 mg Xiliarxa na dan u kombinaciji s metforminom u dvostruko slijepim ispitivanjima (N=208)
English: Table 2 Adverse reactions reported in patients who received Xiliarx 50 mg in combination with a sulphonylurea in double-blind studies (N=170)
Croatian: Tablica 2 Nuspojave zabilježene u bolesnika koji su primali 50 mg Xiliarxa u kombinaciji sa sulfonilurejom u dvostruko slijepim ispitivanjima (N=170)
English: In patients with severe renal impairment, vildagliptin significantly decreased HbA1c compared with placebo (difference of -0.56%) from a mean baseline of
Croatian: U bolesnika s teškim oštećenjem bubrega, vildagliptin je značajno smanjio HbA1c u usporedbi s placebom (razlika od -0,56%) u odnosu na srednju početnu vrijednost od 7,7%.
English: Some patients have had the following side effects while taking Xiliarx, metformin and a sulphonylurea:
Croatian: Neki su bolesnici imali sljedeće nuspojave kada su uzimali Xiliarx i sulfonilureju:
English: Other side effects Some patients have had the following side effects while taking Xiliarx and metformin:
Croatian: Neki su bolesnici imali sljedeće nuspojave kada su uzimali Xiliarx i metformin:
English: How to store Xiliarx
Croatian: Kako čuvati Xiliarx
English: Table 3 Adverse reactions reported in patients who received Xiliarx 100 mg daily in combination with a thiazolidinedione in double-blind studies (N=158)
Croatian: Tablica 3 Nuspojave zabilježene u bolesnika koji su primali 100 mg Xiliarxa na dan u kombinaciji s tiazolidindionom u dvostruko slijepim ispitivanjima (N=158)
English: • Uncommon: Diarrhoea, flatulence
Croatian: • Manje često: proljev, nadutost
English: Table 4 Adverse reactions reported in patients who received Xiliarx 100 mg daily as monotherapy in double-blind studies (N=1,855)
Croatian: Tablica 4 Nuspojave zabilježene u bolesnika koji su primali 100 mg Xiliarxa na dan kao monoterapiju u dvostruko slijepim ispitivanjima (N=1855)
English: Some patients have had the following side effects while taking Xiliarx alone: • Common: Dizziness
Croatian: Neki su bolesnici imali sljedeće nuspojave kada su uzimali samo Xiliarx:
English: • Uncommon: Headache, constipation, swollen hands, ankle or feet (oedema), joint pain, low blood glucose • Very rare: Sore throat, runny nose, fever
Croatian: Neki su bolesnici imali sljedeće nuspojave kada su uzimali Xiliarx, metformin i sulfonilureju: • Često: omaglica, tremor, slabost, niska razina glukoze u krvi, pojačano znojenje
English: • Very rare (may affect up to 1 in 10,000 people): Sore throat, runny nose Some patients have had the following side effects while taking Xiliarx and a glitazone:
Croatian: • Vrlo rijetko (mogu se javiti u do 1 na 10 000 osoba): grlobolja, curenje iz nosa
English: 23 June 2014 EMA/427574/2014
Croatian: 23. lipnja 2014. EMA/427574/2014
English: • Patients who have any concerns about their treatment should speak to their doctor or pharmacist.
Croatian: • Bolesnici koji imaju bilo kakve bojazni oko svog liječenja trebaju se obratiti svom liječniku ili ljekarniku.
English: A neurotransmitter is a chemical that carries signals between nerve cells.
Croatian: Neurotransmiter je kemikalija koja prenosi signale između živčanih stanica.
English: The review of zolpidem-containing medicines was initiated on 4 July 2013 at the request of the Italian Medicines Agency (AIFA) under Article 31 of Directive 2001/83/EC.
Croatian: Procjena lijekova koji sadrže zolpidem započela je 4. srpnja 2013. godine na zahtjev talijanske Agencije za lijekove (AIFA) u skladu s člankom 31. Direktive 2001/83/EZ.
English: Zolpidem has been authorised via national procedures in all Member States of the EU.
Croatian: Zolpidem je odobren nacionalnim postupcima u svim državama članicama EU-a.
English: The CMDh is a medicines regulatory body representing the European Union (EU) Member States
Croatian: 1 CMDh je regulatorno tijelo za lijekove koje predstavlja države članice Europske unije (EU)
English: By stimulating the receptor, zolpidem is able to enhance this effect, helping patients to sleep.
Croatian: Stimulacijom receptora, zolpidem je u stanju pojačati ovaj učinak te tako pomoći bolesnicima da zaspu.
English: A review of these data was first conducted by the Pharmacovigilance Risk Assessment Committee (PRAC).
Croatian: Povjerenstvo za ocjenu rizika u farmakovigilanciji (PRAC) prvo je provelo pregled ovih podataka.
English: Furthermore, patients should not drive or perform activities that require mental alertness for at least 8 hours after taking zolpidem.
Croatian: Nadalje, bolesnici ne smiju voziti ili provoditi aktivnosti koje zahtijevaju mentalnu pribranost tijekom najmanje osam sati nakon uzimanja zolpidema.
English: In order to minimise this risk, zolpidem should not be re-taken during the same night.
Croatian: Kako bi se smanjio ovaj rizik Zolpidem ne treba ponovno uzeti tijekom iste noći.
English: It acts by attaching to and stimulating a particular type of receptor on nerve cells called the alpha-1 GABA-A receptor (also called the omega-1 receptor).
Croatian: Djeluje vezivanjem na te stimulacijom posebne vrste receptora na živčanim stanicama zvanih alfa-1 GABA-A receptor (također zvani i omega-1 receptor).
English: Warnings have been introduced to the product information to highlight these risks.
Croatian: U informacije o lijeku uvedena su upozorenja kako bi se naglasili ti rizici.
English: This receptor is part of a system in the brain that normally responds to a neurotransmitter called gamma-aminobutyric acid (GABA) and which reduces the activity of the brain, causing relaxation and sleepiness.
Croatian: Ovaj receptor dio je sustava u mozgu koji normalno odgovara na neurotransmiter zvan gama aminomaslačna kiselina (GABA) i koji smanjuje aktivnost mozga uzrokujući opuštanje i pospanost.